Patents by Inventor Stefanie Rassnick

Stefanie Rassnick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of human umbilical cord tissue-derived cells
    Patent number: 10724105
    Abstract: The invention relates to methods for detecting allogeneic therapeutic cells (such as human umbilical cord tissue-derived cells (hUTC)) in blood. The methods includes the steps of identifying one or more one or more markers positive for allogeneic therapeutic cells (e.g. hUTC) and one or more markers positive for human peripheral blood mononuclear cells (PBMC); providing a blood sample from a patient that has been treated with allogeneic therapeutic cells (e.g. hUTC), analyzing the sample using an assay method to detect one or more markers positive for PBMC and one or more markers positive for allogeneic therapeutic cells (e.g. hUTC); and distinguishing between the PBMC and one or more markers positive for allogeneic therapeutic cells (e.g. hUTC). In one embodiment, the cells are hUTC and the markers positive of hUTC include CD10 and/or CD13 and the one or more markers positive for PBMC includes CD45.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: July 28, 2020
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Haimanti Dorai, Reyna L. Favis, Xiang Yao, Yu Sun, Anthony J. Kihm, Stefanie Rassnick
  • DETECTION OF HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS
    Publication number: 20170335409
    Abstract: The invention relates to methods for detecting allogeneic therapeutic cells (such as human umbilical cord tissue-derived cells (hUTC)) in blood. The methods includes the steps of identifying one or more one or more markers positive for allogeneic therapeutic cells (e.g. hUTC) and one or more markers positive for human peripheral blood mononuclear cells (PBMC); providing a blood sample from a patient that has been treated with allogeneic therapeutic cells (e.g. hUTC), analyzing the sample using an assay method to detect one or more markers positive for PBMC and one or more markers positive for allogeneic therapeutic cells (e.g. hUTC); and distinguishing between the PBMC and one or more markers positive for allogeneic therapeutic cells (e.g. hUTC). In one embodiment, the cells are hUTC and the markers positive of hUTC include CD10 and/or CD13 and the one or more markers positive for PBMC includes CD45.
    Type: Application
    Filed: March 31, 2017
    Publication date: November 23, 2017
    Applicant: DEPUY SYNTHES PRODUCTS, INC.
    Inventors: Haimanti Dorai, Reyna L. Favis, Xiang Yao, Yu Sun, Anthony J. Kihm, Stefanie Rassnick
  • Detection of human umbilical cord tissue derived cells
    Patent number: 9611513
    Abstract: The invention relates to methods for detecting allogeneic therapeutic cells (such as human umbilical cord tissue-derived cells (hUTC)) in blood. The methods includes the steps of identifying one or more one or more markers positive for allogeneic therapeutic cells (e.g. hUTC) and one or more markers positive for human peripheral blood mononuclear cells (PBMC); providing a blood sample from a patient that has been treated with allogeneic therapeutic cells (e.g. hUTC), analyzing the sample using an assay method to detect one or more markers positive for PBMC and one or more markers positive for allogeneic therapeutic cells (e.g. hUTC); and distinguishing between the PBMC and one or more markers positive for allogeneic therapeutic cells (e.g. hUTC). In one embodiment, the cells are hUTC and the markers positive of hUTC include CD10 and/or CD13 and the one or more markers positive for PBMC includes CD45.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: April 4, 2017
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Haimanti Dorai, Reyna L. Favis, Xiang Yao, Yu Sun, Anthony J. Kihm, Stefanie Rassnick